Dr. Ulrica Sehlstedt

Managing Partner

Board of directors

Global Practice Leader, Healthcare & Life Sciences

Sweden

Ulrica brings over 20 years of broad-sector experience to serving clients across the entire healthcare and life science ecosystem.

Education

Stockholm University
PhD Biophysics
Chalmers University of Technology
M.Sc. Chemical Engineering

Past Experience

LightUp Technologies AB
CEO

Ulrica is a Partner in Arthur D. Little’s Stockholm office and heads the Global Healthcare and Life Sciences Practice.

Her work includes strategy development, opportunity assessment, complex procurement, operational & commercial due diligence, change management, and program management, for healthcare suppliers (pharma, Medtech, and biotech companies), providers (public and private), and investors.

Ulrica is passionate about the role of life science research and development as a lever for prosperity and health. 

Before joining Arthur D. Little in 2007, Ulrica spent seven years as CEO of a molecular diagnostics start-up. She has also been a member of the Swedish Research Council’s Scientific Council for Medicine for six years, and served as a Member of the 2007 and 2016 national expert panels in Life Science Technologies for Future Research Leaders, a program launched by the Swedish Foundation for Strategic Research. 

Healthcare life sciences transaction market
Healthcare life sciences transaction market
After record-breaking transaction years in 2020 and 2021, markets cooled down significantly, and transactions came to an almost standstill. While 2023 and 2024 started seeing a rebound, it was largely driven by strategic acquirers taking advantage of private equity (PE) and venture capital’s (VC’s) limited ability to compete.
The brave new world of synthetic biology
The brave new world of synthetic biology
Major impacts, significant challenges
Time to renew your pilot’s license?
Time to renew your pilot’s license?
Five technologies board members and CEOs must keep on their radar screens

Ulrica is a Partner in Arthur D. Little’s Stockholm office and heads the Global Healthcare and Life Sciences Practice.

Her work includes strategy development, opportunity assessment, complex procurement, operational & commercial due diligence, change management, and program management, for healthcare suppliers (pharma, Medtech, and biotech companies), providers (public and private), and investors.

Ulrica is passionate about the role of life science research and development as a lever for prosperity and health. 

Before joining Arthur D. Little in 2007, Ulrica spent seven years as CEO of a molecular diagnostics start-up. She has also been a member of the Swedish Research Council’s Scientific Council for Medicine for six years, and served as a Member of the 2007 and 2016 national expert panels in Life Science Technologies for Future Research Leaders, a program launched by the Swedish Foundation for Strategic Research. 

Healthcare life sciences transaction market
Healthcare life sciences transaction market
After record-breaking transaction years in 2020 and 2021, markets cooled down significantly, and transactions came to an almost standstill. While 2023 and 2024 started seeing a rebound, it was largely driven by strategic acquirers taking advantage of private equity (PE) and venture capital’s (VC’s) limited ability to compete.
The brave new world of synthetic biology
The brave new world of synthetic biology
Major impacts, significant challenges
Time to renew your pilot’s license?
Time to renew your pilot’s license?
Five technologies board members and CEOs must keep on their radar screens

More About Ulrica
  • Stockholm University
    PhD Biophysics
  • Chalmers University of Technology
    M.Sc. Chemical Engineering
  • LightUp Technologies AB
    CEO